Sugi Predict

Sugi Predict / Compounds / SCHEMBL4077369

SCHEMBL4077369

SCHEMBL4077369

CC(C)c1cccc(C(C)C)c1OCCl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ GABRA1 P14867 3/20 0.43
▸ GABRG2 P18507 2/20 0.43
▸ GABRB3 P28472 2/20 0.43
▸ GABRB2 P47870 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ FAAH O00519 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ GABRB1 P18505 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43
▸ HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17537181 0.85 TSHR (0.40) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL17537177 0.85 TSHR (0.40) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL17537100 0.85 TSHR (0.40) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL17537200 0.82 HTR1A (0.35) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL13408054 0.82 TSHR (0.47) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL11112611 0.82 TSHR (0.47) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL9271255 0.79 GABRA1 (0.52) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL28829202 0.78 TSHR (0.45) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL13896644 0.78 TSHR (0.45) TSHRALOX15GABRA1GABRG2GABRB3
SCHEMBL13954295 0.78 GABRA1 (0.54) TSHRALOX15GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102382133-B A kind of preparation of phosphorus propofol sodium and purification process SHAANXI HECHENG PHARMACEUTICAL CO., LTD. (CN) 2016-03-23 — — CN claimed
CN-102399236-A Synthesis method of fospropofol disodium SHANGHAI RECORD PHARMACEUTICALS LTD COMPANY 2012-04-04 — — CN claimed
CN-102382133-A Method for preparing and purifying fospropofol disodium SHAANXI HECHENG PHARMACEUTICAL CO LTD 2012-03-21 — — CN claimed
CN-109387574-B HPLC method for separating and analyzing related substances of sodium phosphopropofol 华创合成制药股份有限公司 2023-06-23 — — CN disclosed
CN-109305990-B Phosphoric acid derivative, preparation method and application 四川海思科制药有限公司 2021-02-26 — — CN disclosed
CN-109305990-A A kind of phosphoric acid derivatives and preparation method and purposes 四川海思科制药有限公司 2019-02-05 — — CN disclosed
CN-107709288-A Phosphamide derivative and preparation method and application thereof 四川海思科制药有限公司 2018-02-16 — — CN disclosed
WO-2017133517-A1 PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF 四川海思科制药有限公司 2017-08-10 — — WO disclosed
WO-2017133517-A1 PHOSPHAMIDE DERIVATIVE, METHOD FOR MANUFACTURING THE SAME, AND USES THEREOF 四川海思科制药有限公司 2017-08-10 — — WO disclosed
CN-102382133-B A kind of preparation of phosphorus propofol sodium and purification process SHAANXI HECHENG PHARMACEUTICAL CO., LTD. (CN) 2016-03-23 — — CN disclosed
CN-102382133-B A kind of preparation of phosphorus propofol sodium and purification process SHAANXI HECHENG PHARMACEUTICAL CO., LTD. (CN) 2016-03-23 — — CN disclosed
US-7229978-B2 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol MGI GP, INC. (US) 2007-06-12 — — US disclosed
US-7229978-B2 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol MGI GP, INC. (US) 2007-06-12 — — US disclosed
US-20070043206-A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol MGI GP, INC. (US) 2007-02-22 — — US disclosed
US-20070043206-A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol MGI GP, INC. (US) 2007-02-22 — — US disclosed
US-20070043206-A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol MGI GP, INC. (US) 2007-02-22 — — US disclosed
EP-1471920-A4 PROCESS FOR PREPARING WATER-SOLUBLE PHOSPHONOOXYMETHYL DERIVATIVES OF ALCOHOL AND PHENOL GUILFORD PHARM INC (US) 2006-02-15 — — EP disclosed
US-20050124787-A1 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol EISAI INC. 2005-06-09 — — US disclosed
EP-1471920-A2 PROCESS FOR PREPARING WATER-SOLUBLE PHOSPHONOOXYMETHYL DERIVATIVES OF ALCOHOL AND PHENOL GUILFORD PHARMACEUTICALS INC. (US) 2004-11-03 — — EP disclosed
WO-2003059255-A2 PROCESS FOR PREPARING WATER-SOLUBLE PHOSPHONOOXYMETHYL DERIVATIVES OF ALCOHOL AND PHENOL GUILFORD PHARMACEUTICALS, INC. (US) 2003-07-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124787-A1 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol CYP2E1, PHOSPHO1, SMARCE1 TSHR 3403/4885ALOX15 2387/4885GABRA1 1580/4885
US-20070043206-A1 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol PHOSPHO1, CD69, CYP2E1 TSHR 3449/4885ALOX15 2154/4885GABRA1 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.